Literature DB >> 11268709

The prevention of breast cancer: an overview.

C Leris1, K Mokbel.   

Abstract

The role of lifestyle modifications, antioestrogens, cyclo-oxygenase-2 inhibitors and prophylactic mastectomy in reducing breast cancer is reviewed. It is concluded that avoiding postmenopausal obesity and regular physical activity are simple measures that seem to reduce breast cancer risk. There is no conclusive evidence that dietary modification and vitamin supplementation significantly reduce the risk of breast cancer. The evidence suggests that tamoxifen significantly reduces the risk of breast cancer in women at increased risk, but whether it reduces breast cancer mortality remains unknown. Ongoing clinical trials may prove that raloxifene is superior to tamoxifen in breast cancer prevention due to its anti-oestrogenic effects on the endometrium. Bilateral prophylactic mastectomy reduces the risk of breast cancer by 90% in high risk women.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11268709     DOI: 10.1185/030079901750120187

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  5 in total

1.  Breast cancer prevention.

Authors:  Kefah Mokbel
Journal:  Br J Gen Pract       Date:  2002-12       Impact factor: 5.386

2.  Participating in primary care research.

Authors:  Robert K McKinley; Mary Dixon-Woods; Hazel Thornton
Journal:  Br J Gen Pract       Date:  2002-12       Impact factor: 5.386

3.  Tamoxifen increases photodynamic therapeutic response of U87 and U25ln human glioma cells.

Authors:  Feng Jiang; Kyung-Keun Cho; Tom Mikkelse; Ling Tong; Young S Lew; Nechama Hochbaum; Josef Shargorodsky; Michael Chop
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

Review 4.  Prophylactic interventions on children: balancing human rights with public health.

Authors:  F M Hodges; J S Svoboda; R S Van Howe
Journal:  J Med Ethics       Date:  2002-02       Impact factor: 2.903

5.  17α-ethynyl-5α-androstane-3α, 17β-diol treatment of MNU-induced mammary cancer in rats.

Authors:  Clarence N Ahlem; James M Frincke; Steven K White; Christopher L Reading; Richard J Trauger; Rajkumar Lakshmanaswamy
Journal:  Int J Breast Cancer       Date:  2011-02-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.